0000000000405990

AUTHOR

Concetta Sergi

showing 9 related works from this author

Morphological features of the idiopathic dilated cardiomyopathy.

2007

researchProduct

CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.

2008

AIMS: CD1a is a molecule belonging to the highly conserved group of CD1 proteins. Its expression in dendritic cells is related to the presentation of tumour-derived glycolipid antigens to T cells and, consequently, the development of a successful antitumour response. The aim was to investigate the presence of CD1a+ cells in both primary tumours and lymph nodes (LN) of a series of 35 invasive ductal carcinomas by both immunohistochemistry and reverse transcription-polymerase chain reaction. METHODS AND RESULTS: CD1a antigen was more expressed in N0 than N1 breast cancer (P < 0.0001) in both primary lesions and LN metastases and correlated positively and significantly with oestrogen (ER) (P =…

AdultCD4-Positive T-LymphocytesCarcinoma Ductal BreastDown-RegulationBreast NeoplasmsDendritic CellsCD8-Positive T-LymphocytesMiddle AgedCD1APrognosisImmunohistochemistryAntigens CD1Gene Expression Regulation NeoplasticReceptors EstrogenPredictive Value of TestsLymphatic MetastasisHumansFemaleReceptors ProgesteroneAged
researchProduct

Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer

2021

To date, the virtual multidisciplinary tumor boards (vMTBs) are increasingly used to achieve high-quality treatment recommendations across health-care regions, which expands and develops the local MTB team to a regional or national expert network. This review describes the process of lung cancer-specific MTBs and the transition process from face-to-face tumor boards to virtual ones. The review also focuses on the project organization's description, advantages, and disadvantages. Semi-structured interviews identified five major themes for MTBs: current practice, attitudes, enablers, barriers, and benefits for the MTB. MTB teams exhibited positive responses to modeled data feedback. Virtualiz…

Pulmonary and Respiratory MedicineMultidisciplinary tumor boardsTeamworkProcess managementReferralProcess (engineering)Computer sciencemedia_common.quotation_subjectReviewVirtualizationcomputer.software_genremedicine.diseaseOncology networksClinical trialVirtualizationMultidisciplinary approachRespiratory CaremedicineNarrative reviewLung cancerLung cancercomputermedia_commonPulmonary Therapy
researchProduct

Examining perceptions of financial toxicity among cancer patients: The Financial Toxicity 16 Questionnaire.

2020

e19389 Background: Financial toxicity (FT) among cancer patients (CP) is multifactorial, arising from both disease-related and non- disease related factors, including socio-cultural, environmental, and psychological attributes. It derives both from costs related to assistance and borne on the patients and its caregivers, and reduction of income capacity also in this case borne on the patients and on the caregivers. Stress levels may escalate to significant proportions in some patient, to present with symptoms of anxiety especially during therapy administration periods. Methods: In order to highlight financial toxicity related to the diagnosis of metastatic pancreatic and lung cancer and to…

Related factorsFinanceCancer ResearchOncologybusiness.industryToxicitymedicineCancerDiseasemedicine.diseasebusinessJournal of Clinical Oncology
researchProduct

Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity

2021

Abstract Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability …

medicine.medical_specialtybusiness.industryCancerHematologymedicine.diseaseMedical careDistressIndirect costsCost of IllnessOncologyHealth caremedicineHumansPatient CareGastrointestinal cancerHealth ExpendituresbusinessIntensive care medicineMedical costsPsychosocialhealth care economics and organizationsGastrointestinal NeoplasmsCritical Reviews in Oncology/Hematology
researchProduct

ANP and CD34 expression in human dilated cardiomiopathies: a new insight

2006

researchProduct

Morphological features of the idiopathic dilated cardiomyopathy

2007

researchProduct

ANP and CD34 Expression in Human Dilated Cardiomiophaties: a new insight.

2006

researchProduct

Virtual Multidisciplinary Tumor Board: A Narrative Review Focused on Lung Cancer

2021

Article full text The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The authors, CC-BY-NC 2021.

researchProduct